FN2 Earnings Intelligence
Incyte Corporation financials
Incyte Corporation (INCY) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $2,057.4 | $2,951.4 | $3,213.4 | $1,687.8 | $3,097.8 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $2,986.3 | $3,394.6 | $3,695.6 | $4,241.2 | $5,141.2 | $5,818.7 | $6,205.1 |
| % Growth | 12.0% | 13.7% | 8.9% | 14.8% | 21.2% | 13.2% | 6.6% |
| Gross Profit | $2,835.3 | $3,187.6 | $3,440.7 | $3,929.1 | $4,769.1 | - | - |
| % Margin | 94.9% | 93.9% | 93.1% | 92.6% | 92.8% | - | - |
| EBITDA | $643.6 | $647.3 | $703.2 | $150.6 | $1,608.1 | - | - |
| % Margin | 21.6% | 19.1% | 19.0% | 3.6% | 31.3% | - | - |
| Net Income | $948.6 | $340.7 | $597.6 | $32.6 | $1,286.6 | - | - |
| % Margin | 31.8% | 10.0% | 16.2% | 0.8% | 25.0% | - | - |
| Diluted EPS | $4.27 | $1.52 | $2.65 | $0.15 | $6.41 | $5.33 | $8.70 |
| % Growth | 414.0% | -64.4% | 74.3% | -94.3% | 4,173.3% | -16.8% | 63.3% |
| Operating Cash Flow | $749.5 | $969.9 | $496.5 | $335.3 | $1,413.5 | - | - |
| CapEx | $181 | $77.8 | - | - | - | - | - |
| Free Cash Flow | $568.5 | $892.1 | - | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $2,986.3 | $3,394.6 | $3,695.6 | $4,241.2 | $5,141.2 | $5,818.7 | $6,205.1 |
| Gross Profit | $2,835.3 | $3,187.6 | $3,440.7 | $3,929.1 | $4,769.1 | - | - |
| EBITDA | $643.6 | $647.3 | $703.2 | $150.6 | $1,608.1 | - | - |
| Net Income | $948.6 | $340.7 | $597.6 | $32.6 | $1,286.6 | - | - |
| Diluted EPS | $4.27 | $1.52 | $2.65 | $0.15 | $6.41 | $5.33 | $8.70 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2,057.4 | $2,951.4 | $3,213.4 | $1,687.8 | $3,097.8 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $749.5 | $969.9 | $496.5 | $335.3 | $1,413.5 |
| Capital Expenditure | $181 | $77.8 | - | - | - |
| Free Cash Flow | $568.5 | $892.1 | - | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 12.0% | 13.7% | 8.9% | 14.8% | 21.2% |
| Gross Margin | 94.9% | 93.9% | 93.1% | 92.6% | 92.8% |
| EBITDA Margin | 21.6% | 19.1% | 19.0% | 3.6% | 31.3% |
| Net Margin | 31.8% | 10.0% | 16.2% | 0.8% | 25.0% |
| FCF Margin | 19.0% | 26.3% | - | - | - |
| Diluted EPS Growth | 414.0% | -64.4% | 74.3% | -94.3% | 4,173.3% |